These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 13844020)

  • 1. [On the purification and specificity of DOPA-decarboxylase].
    WERLE E; AURES D
    Hoppe Seylers Z Physiol Chem; 1959 Sep; 316():45-60. PubMed ID: 13844020
    [No Abstract]   [Full Text] [Related]  

  • 2. [On purification and specificity of DOPA decarboxylase].
    WERLE E; AURES D
    Psychiatr Neurol (Basel); 1960 Jul; 140():227-36. PubMed ID: 13784426
    [No Abstract]   [Full Text] [Related]  

  • 3. Activation of DOPA decarboxylase by pyridoxal phosphate.
    AWAPARA J; SANDMAN RP; HANLY C
    Arch Biochem Biophys; 1962 Sep; 98():520-5. PubMed ID: 13863437
    [No Abstract]   [Full Text] [Related]  

  • 4. Are dihydroxphenylalanine decarboxylase and 5-hydroxytrptophan decarboxylase individual enzymes?
    ROSENGREN E
    Acta Physiol Scand; 1960 Aug; 49():364-9. PubMed ID: 13743456
    [No Abstract]   [Full Text] [Related]  

  • 5. Microanalytical procedures for fluorometric assay of brain DOPA-5HTP decarboxylase, norepinephrine and serotonin, and a detailed mapping of decarboxylase activity in brain.
    KUNTZMAN R; SHORE PA; BOGDANSKI D; BRODIE BB
    J Neurochem; 1961 Feb; 6():226-32. PubMed ID: 13755185
    [No Abstract]   [Full Text] [Related]  

  • 6. DOPA decarboxylase inhibition through the interaction of coenzyme and substrate.
    SCHOTT HF; CLARK WG
    J Biol Chem; 1952 May; 196(1):449-62. PubMed ID: 12980987
    [No Abstract]   [Full Text] [Related]  

  • 7. [Pharmacological antagonism between pyridoxal 5-phosphate (activator of DOPA decarboxylase) and certain hydrazines (inhibitors of monoamine oxidase)].
    LEVY J; MICHEL-BER E
    C R Hebd Seances Acad Sci; 1960 Jun; 250():4061-3. PubMed ID: 14416402
    [No Abstract]   [Full Text] [Related]  

  • 8. [The effect of thyroxin and starvation on the activity of amine oxidase and DOPA-decarboxylase in liver].
    HOLTZ P; STOCK K; WESTERMANN E
    Naunyn Schmiedebergs Arch Exp Pathol Pharmakol; 1956; 228(3):322-30. PubMed ID: 13334654
    [No Abstract]   [Full Text] [Related]  

  • 9. Observations on the substrate specificity of DOPA decarboxylase from ox adrenal medulla, human phaeochromocytoma and human argentaffinoma.
    HAGEN P
    Br J Pharmacol Chemother; 1962 Feb; 18(1):175-82. PubMed ID: 13903593
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Purification and properties of adrenal L-DOPA decarboxylase.
    FELLMAN JH
    Enzymologia; 1959 Jul; 20():366-76. PubMed ID: 13822118
    [No Abstract]   [Full Text] [Related]  

  • 11. [Nerve tissue DOPA decarboxylase and histidine decarboxylase].
    HOLTZ P; WESTERMANN E
    Naunyn Schmiedebergs Arch Exp Pathol Pharmakol; 1956; 227(6):538-46. PubMed ID: 13334561
    [No Abstract]   [Full Text] [Related]  

  • 12. Competitive inhibition of 3, 4-dihydroxyphenylalanine (DOPA) decarboxylase in vitro.
    HARTMAN WJ; AKAWIE RI; CLARK WG
    J Biol Chem; 1955 Oct; 216(2):507-29. PubMed ID: 13271331
    [No Abstract]   [Full Text] [Related]  

  • 13. [ON TYROSINE METABOLISM IN INSECTS. XII. PURIFICATION, PROPERTIES AND SUBSTRATE SPECIFICITY OF DOPA-DECARBOXYLASE].
    SEKERIS CE
    Hoppe Seylers Z Physiol Chem; 1963; 332():70-8. PubMed ID: 14054806
    [No Abstract]   [Full Text] [Related]  

  • 14. Inhibition of DOPA decarboxylase in vitro and in vivo.
    CLARK WG; POGRUND RS
    Circ Res; 1961 May; 9():721-33. PubMed ID: 13693869
    [No Abstract]   [Full Text] [Related]  

  • 15. [The effects of hydrazine and guanylhydrazone derivatives on the activity of monoamine oxidase, diamine oxidase, DOPA decarboxylase and histidine decarboxylase].
    WERLE E; SCHAUER A; HARTUNG G
    Klin Wochenschr; 1955 Jun; 33(23-24):562-7. PubMed ID: 14392887
    [No Abstract]   [Full Text] [Related]  

  • 16. [Purification of microbial histidine decarboxylase].
    MARDASHEV SR; MAMAEVA VV
    Mikrobiologiia; 1961; 30():530-3. PubMed ID: 13766611
    [No Abstract]   [Full Text] [Related]  

  • 17. Inhibition of DOPA decarboxylase by aromatic acids associated with phenylpyruvic oligophrenia.
    FELLMAN JH
    Proc Soc Exp Biol Med; 1956 Dec; 93(3):413-4. PubMed ID: 13389476
    [No Abstract]   [Full Text] [Related]  

  • 18. [Effect of thyroxin and triiodothyronine on the activity of amine oxydase and DOPA decarboxylase in liver].
    WESTERMANN E
    Naunyn Schmiedebergs Arch Exp Pathol Pharmakol; 1956; 228(1-2):159-60. PubMed ID: 13334595
    [No Abstract]   [Full Text] [Related]  

  • 19. Gastric dopa decarboxylase, histidine decarboxylase and serotonin, following immunosympathectomy in rats.
    Aures D; Thompson JH
    Eur J Pharmacol; 1971 Oct; 16(2):225-8. PubMed ID: 5161261
    [No Abstract]   [Full Text] [Related]  

  • 20. Congenital hyperinsulinism: pancreatic [18F]fluoro-L-dihydroxyphenylalanine (DOPA) positron emission tomography and immunohistochemistry study of DOPA decarboxylase and insulin secretion.
    de Lonlay P; Simon-Carre A; Ribeiro MJ; Boddaert N; Giurgea I; Laborde K; Bellanné-Chantelot C; Verkarre V; Polak M; Rahier J; Syrota A; Seidenwurm D; Nihoul-Fékété C; Robert JJ; Brunelle F; Jaubert F
    J Clin Endocrinol Metab; 2006 Mar; 91(3):933-40. PubMed ID: 16403819
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.